Literature DB >> 18193442

Breast cancer, ovarian gonadoblastoma and cervical cancer in a patient with Peutz-Jeghers Syndrome.

Tulay Kilic-Okman1, Turgut Yardim, Fatih Gücer, Semsi Altaner, M Ali Yuce.   

Abstract

BACKGROUND: Peutz-Jeghers Syndrome (PJS) is a rare autosomal dominant disorder characterized by gastrointestinal hamartomatous polyps and mucocutaneous pigmentation. Patients with PJS have increased risk for gastrointestinal, breast, and female genital tract cancers. CASE: Multiple genital tract cancers in a 34-year-old woman with PJS are described. The patient, who was admitted to our department with severe vaginal bleeding, was performed right salpingo-oophorectomy because of pure gonadoblastoma in 1996. In 2003, concomitant to cervical carcinoma, breast cancer was diagnosed. Patient underwent left modified radical mastectomy due to the invasive papillary carcinoma. The patient received six cycles combination chemotherapy and radiation therapy because of stage IIIB cervical cancer. CONCLUSION(S): This is the first case report presenting PJS associated with multiple genital tract tumors including ovarian gonadoblastoma in literature. The clinical significance of these tumors in PJS patients has been reviewed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18193442     DOI: 10.1007/s00404-007-0535-x

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  2 in total

1.  Specific Alu elements involved in a significant percentage of copy number variations of the STK11 gene in patients with Peutz-Jeghers syndrome.

Authors:  Pawel Borun; Marina De Rosa; Boguslaw Nedoszytko; Jaroslaw Walkowiak; Andrzej Plawski
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

2.  Hamartomatous polyposis syndromes.

Authors:  Zoran Stojcev; Pawel Borun; Jacek Hermann; Piotr Krokowicz; Wojciech Cichy; Lukasz Kubaszewski; Tomasz Banasiewicz; Andrzej Plawski
Journal:  Hered Cancer Clin Pract       Date:  2013-06-01       Impact factor: 2.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.